Keyphrases
Cannabigerol
83%
Anti-inflammatory Properties
75%
Pincer Ligands
50%
Inflammation Pain
50%
Phytocannabinoids
50%
Iridium Complex
50%
Obesity
50%
Novel Synthesis
50%
Acridine
50%
Ligand Reactivity
50%
Ligand Structure
50%
High-fat Diet
37%
Cannabidiol
33%
New Derivatives
33%
Inflammatory Conditions
29%
Novel Drug Candidates
29%
Ir Complexes
20%
Ir(I) Complex
20%
Interleukin-1β
16%
In Vivo Model
16%
Novel Therapeutics
16%
Derivatization
16%
Biological Evaluation
16%
Cytokine Levels
16%
Parent Compounds
16%
Potential for Development
12%
Therapeutic Benefits
12%
Liver Slices
12%
Analgesic Properties
12%
Unmet Needs
12%
Metabolic State
12%
Steatosis
12%
High-fat Diet Mice
12%
P,N-ligands
10%
Hydrides
10%
Structural Flexibility
10%
Oxidative Addition
10%
Metal Center
10%
Olefins
10%
Aromatization
10%
Unique Properties
10%
Ruthenium Complexes
10%
Ru(II) Complexes
10%
Ligand Complexes
10%
Chemistry
Cannabigerol
83%
Antiinflammatory
75%
Phytocannabinoid
50%
Iridium
50%
Acridine
50%
Olivetol
33%
Cannabidiol
33%
Cannabichromene
16%
Derivatization
16%
Dexamethasone
16%
Metabolic
12%
Isopropyl Group
10%
Oxidative Addition
10%
Ruthenium
10%
Alkene
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabigerol
100%
Inflammation
75%
Anti-Inflammatory Drug
75%
Olivetol
50%
Dexamethasone
25%
Cytokine
25%
Cannabidiol
25%
Cannabichromene
25%
Cannabidiol Derivative
25%
Steatosis
12%
Analgesic Agent
12%
